Fourth UCLH patient to be given innovative treatment for CJD

A fourth patient of University College London Hospitals NHS Foundation Trust (UCLH) is to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD) following a ruling from the Court of Protection.